Pays to keep an eye on what Mike Snape and Joe Horrigan (previously Neuren) are beavering away on. I have a lot of respect for Snape from the science perspective - not sure what type of CEO he is at AMO.
Snape, in my view, gave a most (the most) discerning and influential explanation of the potential of Trofinetide back in the day, and if you are new here and haven't seen this - then you should! I think it might be the third time I have posted it over these many years.
Prof Mike Snape - NNZ-2566 in Rett Syndrome and Autism Spectrum Disorders
Bellus > AMO-01 > Frag X > AMO
Trump, Big Pharma and orphan drugs, page-26
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.13 |
Change
0.020(0.15%) |
Mkt cap ! $1.678B | |||
| Open | High | Low | Value | Volume |
| $13.20 | $13.44 | $13.07 | $5.021M | 378.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 11501 | $13.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.18 | 1539 | 1 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |